Log In
|
Recently Purchased
|
Favorites
|
My COAs
|
Cart
(0)
OVERVIEW
INNOVATIONS
COMPANY PROFILE
OUR EXPERTS
FACILITY
OVERVIEW
QUALITY CREDENTIALS
COA EXAMPLES
EXPIRY/RETEST DATES
OVERVIEW
SYNTHESIS
CERTIFIED SOLUTION
STANDARDS
CERTIFICATIONS
PACKAGING
INVENTORY MANAGEMENT
& DISTRIBUTION
OEM & PRIVATE LABEL
REQUEST QUOTE
CATALOG
NEW PRODUCTS
ORDERING INFORMATION
REQUEST/DOWNLOAD
CATALOG
REQUEST CUSTOM QUOTE
SEARCH COAs/SDSs
PAPERS & POSTER
PRESENTATIONS
CONTACT INFORMATION
INTERNATIONAL SALES
CAREERS
LOG IN/REQUEST LOGIN
FAVORITES
RECENTLY PURCHASED
QUICK ORDER
ORDER HISTORY
PURCHASES BY ITEM
MY ACCOUNT'S COAs & SDSs
VIEW CART/CHECK OUT
25-February-2011
Cerilliant Introduces New Certified Solution Standard of Digitoxin
Digitoxin, 1.0 mg/mL
D-067
1.0 mg/mL in Methanol
A cardiac glycoside and antiarrhythmic drug similar in structure and effect to digoxin. Digitoxin is monitored by clinical labs to ensure patients remain within the drug’s therapeutic range.
In addition to digitoxin and digoxin (
D-029
), we offer certified solution standards of other
antiarrhythmic
drugs as well as
antihypertensive
and other
cardiac drugs
. We also offer Certified Spiking Solutions
®
of numerous drugs assayed in
therapeutic drug monitoring
Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO 17034 and ISO/IEC 17025 & certified ISO 9001.
All New Product Announcements
©
2024
Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany
Products
|
Sitemap
|
Privacy Policy
|
EHS Policy
|
Terms & Conditions
|
Contact